Norwalk Gastroenteritis

• CLINICAL_TRIALS trial_result · 2026-01-16
  Clinical Trial Update: Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula Polymorpha) [Phase 3]

  Phase III trial evaluating a recombinant human norovirus bivalent GI.1/GII.4 vaccine completed, sponsored by the National Vaccine and Serum …

• CLINICAL_TRIALS trial_result · 2022-10-28
  Clinical Trial Update: Clinical Trial to Evaluate the Recombinant Norovirus Bivalent (GI. 1 / GII. 4) Vaccine (Hansenula Polymorpha) [Phase 2]

  Phase 2 clinical trial evaluating a recombinant norovirus bivalent vaccine (GI.1/GII.4) produced in Hansenula polymorpha for Norovirus infec…